Investing
By Ben Glickman Oragenics said it would transfer assets to Lantern Bioworks. Oragenics said it would receive $50,000 in cash, the right to acquire...
Hi, what are you looking for?
IntelTEXTA
IntelTEXTA
Investing
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s highlights of the most timely ETF news emailed to you weekly....
Investing
In these times of deep divisions, one thing Americans can agree on is the Super Bowl. It has become our secular version of Carnival...
Investing
A glimmer of hope appeared Friday for beleaguered New York Community Bancorp after its stock rose 17% on strong trading volume. Investors seemed reassured...
Investing
Commodities are now so out of fashion with investors that it seems likely they’ll rally soon. The investing asset class, which includes energy, foodstuffs...
Investing
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed to you weekly! INVESTING...
Investing
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than...
Investing
Gold prices took a tumble over the last month. But experts say there’s reason to be optimistic for a bounce back in short order....
Investing
The United Auto Workers union is expanding its strike against General Motors and Ford Motor, targeting one assembly plant at each company. Electric vehicles...
Investing
Last weekend I explained how that week’s market decline carried many negative factors, but needed a second week’s confirmation to be taken seriously. That...
Investing
In the year and a half since Russia launched its invasion of Ukraine, Ukraine’s government has been working to boost its economy with the...
Investing
It might be a value stock if you can pick it up at below book value. That it’s making money and paying dividends makes...
Investing
Lexeo Therapeutics filed for an IPO on Friday. The company develops genetic medicines, with candidates for treatment of Friedreich’s ataxia and Alzheimer’s currently being...
